Correlation Between Pfizer and PTC Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and PTC Therapeutics, you can compare the effects of market volatilities on Pfizer and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and PTC Therapeutics.

Diversification Opportunities for Pfizer and PTC Therapeutics

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and PTC is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and PTC Therapeutics go up and down completely randomly.

Pair Corralation between Pfizer and PTC Therapeutics

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the PTC Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 2.39 times less risky than PTC Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The PTC Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  3,252  in PTC Therapeutics on August 27, 2024 and sell it today you would earn a total of  1,071  from holding PTC Therapeutics or generate 32.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  PTC Therapeutics

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
PTC Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PTC Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, PTC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and PTC Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and PTC Therapeutics

The main advantage of trading using opposite Pfizer and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.
The idea behind Pfizer Inc and PTC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals